Integrating such multi-omics technologies with functional studies of LKB1-associated pathways—particularly the interplay between the STAT3/LKB1/mTORC1/CREB axis and canonical PCa drivers—will be instrumental in uncovering actionable therapeutic targets (Pencik et al., 2023). This evidence concerns the gene CREB1 and posterior cortical atrophy.